CVB4 can strongly induce IFN-alpha production by PBMCs from patients with type 1 diabetes through interactions with circulating and/or cell-bound IgGs.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for CVB4 in type 1 diabetes pathogenesis; leaves open clinical relevance pending validation.
Hober et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: